> top > docs > PMC:7117596 > annotations

PMC:7117596 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T185 13981-13989 SP_7 denotes COVID-19
T184 8621-8629 SP_7 denotes COVID-19
T183 8736-8747 UBERON:0001004 denotes respiratory
T182 8932-8947 CHEBI:36044;CHEBI:36044 denotes antiviral drugs
T181 8951-8960 CHEBI:31781;CHEBI:31781;DG_23 denotes lopinavir
T180 8961-8970 DG_30 denotes ritonavir
T179 8994-9004 DG_28 denotes remdesivir
T178 9039-9050 CHEBI:3638;CHEBI:3638;DG_10 denotes chloroquine
T177 9055-9073 CHEBI:5801;CHEBI:5801;DG_20 denotes hydroxychloroquine
T176 9118-9126 SP_7 denotes COVID-19
T175 9189-9197 GO:0042571 denotes antibody
T174 9205-9216 DG_35 denotes tocilizumab
T173 9234-9239 SP_6;NCBITaxon:9606 denotes human
T172 9240-9244 PR:000001393 denotes IL-6
T171 9296-9307 DG_35 denotes Tocilizumab
T170 9696-9707 DG_35 denotes tocilizumab
T169 9737-9743 UBERON:0002405 denotes immune
T168 9771-9775 PR:000001919 denotes PD-1
T167 9905-9916 DG_35 denotes tocilizumab
T166 9944-9952 SP_7 denotes COVID-19
T165 10013-10023 SP_7 denotes SARS-CoV-2
T164 10114-10119 NCBITaxon:10239 denotes viral
T163 10244-10252 SP_7 denotes COVID-19
T162 10308-10314 UBERON:0002405;GO:0006955 denotes immune
T161 10315-10323 GO:0006955 denotes response
T160 10458-10469 UBERON:0001004 denotes respiratory
T159 10910-10916 UBERON:0002405 denotes immune
T158 11100-11110 SP_7 denotes SARS-CoV-2
T157 11264-11270 UBERON:0002405 denotes immune
T156 11307-11315 SP_7 denotes COVID-19
T155 11348-11358 SP_7 denotes SARS-CoV-2
T154 11503-11517 GO:0010467 denotes overexpression
T153 11521-11538 CHEBI:35705;CHEBI:35705 denotes immunosuppressive
T152 11606-11615 GO:0030425;CL:0000451 denotes dendritic
T151 11616-11620 CL:0000451;GO:0048469 denotes cell
T150 11621-11631 GO:0048469 denotes maturation
T149 11646-11663 CHEBI:35705;CHEBI:35705 denotes immunosuppressive
T148 11664-11673 CL:0000738 denotes leukocyte
T147 11717-11723 UBERON:0002405 denotes immune
T146 11837-11848 UBERON:0001004 denotes respiratory
T145 11931-11941 SP_7 denotes SARS-CoV-2
T144 12039-12045 UBERON:0002405 denotes immune
T143 12093-12104 DG_35 denotes tocilizumab
T142 12109-12117 SP_7 denotes COVID-19
T141 12306-12310 PR:000001393 denotes IL-6
T140 12431-12436 SP_6;NCBITaxon:9606 denotes human
T139 12437-12446 NCBITaxon:7719 denotes influenza
T138 12447-12452 NCBITaxon:10239 denotes virus
T137 12538-12542 NCBITaxon:10088 denotes mice
T136 12555-12559 PR:000001393 denotes IL-6
T135 12588-12593 NCBITaxon:10239 denotes virus
T134 12602-12612 CL:0000775 denotes neutrophil
T133 12613-12617 CL:0000775;GO:0008219 denotes cell
T132 12618-12623 GO:0008219 denotes death
T131 12726-12730 UBERON:0002048 denotes lung
T130 12760-12764 PR:000001393 denotes IL-6
T129 12810-12815 NCBITaxon:10239 denotes virus
T128 12825-12831 GO:0007613 denotes memory
T127 12832-12835 PR:000001004 denotes CD4
T126 12836-12843 CL:0000084 denotes T cells
T125 12854-12859 NCBITaxon:10239 denotes virus
T124 12922-12926 PR:000001393 denotes IL-6
T123 12937-12941 NCBITaxon:10088 denotes mice
T122 12953-12962 NCBITaxon:7719 denotes influenza
T121 12963-12968 NCBITaxon:10239 denotes viral
T120 12983-12987 UBERON:0002048 denotes lung
T119 13085-13089 PR:000001393 denotes IL-6
T118 13139-13144 NCBITaxon:10239 denotes viral
T117 13263-13274 DG_35 denotes tocilizumab
T116 13304-13312 SP_7 denotes COVID-19
T115 13379-13384 NCBITaxon:10239 denotes viral
T114 13409-13413 SP_10 denotes SARS
T113 3825-3833 SP_7 denotes COVID-19
T112 4229-4237 SP_7 denotes COVID-19
T111 4375-4383 SP_7 denotes COVID-19
T110 4504-4515 NCBITaxon:11118 denotes coronavirus
T109 4524-4536 UBERON:0005169 denotes interstitial
T108 4597-4601 PR:000001919 denotes PD-1
T107 4624-4628 UBERON:0002048 denotes lung
T106 4695-4699 UBERON:0000104 denotes life
T105 4796-4800 PR:000001919 denotes PD-1
T104 4801-4806 PR:000001543 denotes PD-L1
T103 4838-4844 PR:000001852 denotes CTLA-4
T102 4850-4854 PR:000001919 denotes PD-1
T101 4918-4922 UBERON:0002048 denotes lung
T100 4923-4929 UBERON:0002405 denotes immune
T99 5078-5090 UBERON:0005169 denotes interstitial
T98 5196-5200 PR:000001919 denotes PD-1
T97 5201-5206 PR:000001543 denotes PD-L1
T96 5207-5216 CHEBI:35222;CHEBI:35222 denotes inhibitor
T95 5272-5278 GO:0016265 denotes deaths
T94 5313-5317 UBERON:0002048 denotes lung
T93 5350-5362 UBERON:0005169 denotes interstitial
T92 5551-5559 SP_7 denotes COVID-19
T91 5589-5593 UBERON:0002048 denotes lung
T90 5842-5850 SP_7 denotes COVID-19
T89 6082-6087 UBERON:0002113;CL:1000497 denotes renal
T88 6088-6092 CL:1000497 denotes cell
T87 6114-6122 CHEBI:60809;CHEBI:60809 denotes adjuvant
T86 6280-6288 SP_7 denotes COVID-19
T85 6290-6306 GO:0017156 denotes Cytokine-release
T84 6341-6347 UBERON:0002405 denotes immune
T83 6402-6408 CL:0000084 denotes T cell
T82 6447-6453 CL:0000084 denotes T cell
T81 6476-6480 PR:000001919 denotes PD-1
T80 6537-6541 PR:000001393 denotes IL-6
T79 6543-6549 PR:000000017 denotes IFN- γ
T78 6618-6624 UBERON:0002405;GO:0006955 denotes immune
T77 6625-6635 GO:0042110 denotes activation
T76 6688-6693 UBERON:0000062 denotes organ
T75 6704-6708 UBERON:0002048 denotes lung
T74 6721-6726 GO:0016265 denotes death
T73 6820-6828 SP_7 denotes COVID-19
T72 6884-6895 UBERON:0001004 denotes respiratory
T71 6931-6936 UBERON:0000062 denotes organ
T70 6978-6986 SP_7 denotes COVID-19
T69 7032-7035 PR:000001004 denotes CD4
T68 7044-7051 CL:0000084 denotes T cells
T67 7158-7162 PR:000001202 denotes CCR6
T66 7172-7175 PR:000001004 denotes CD4
T65 7176-7183 CL:0000084 denotes T cells
T64 7211-7218 CL:0000084 denotes T cells
T63 7273-7281 GO:0009542 denotes granules
T62 7314-7316 GO:0042110 denotes of
T61 7317-7324 CL:0000084 denotes T cells
T60 7359-7365 UBERON:0002405 denotes immune
T59 7452-7463 UBERON:0001004 denotes respiratory
T58 7485-7493 SP_7 denotes COVID-19
T57 7510-7522 UBERON:0005169 denotes interstitial
T56 7523-7534 GO:0005634 denotes mononuclear
T55 7566-7571 UBERON:0000170 denotes lungs
T54 7586-7597 CL:0000542 denotes lymphocytes
T53 7628-7634 UBERON:0002405 denotes immune
T52 7701-7709 SP_7 denotes COVID-19
T51 7807-7815 SP_7 denotes COVID-19
T50 7871-7877 UBERON:0002405 denotes immune
T49 8086-8094 SP_7 denotes COVID-19
T48 8304-8309 NCBITaxon:10239 denotes viral
T47 183-189 NCBITaxon:11118 denotes corona
T46 190-195 NCBITaxon:10239 denotes virus
T45 208-216 SP_7 denotes COVID-19
T44 374-386 SP_7 denotes severe acute
T43 387-398 SP_7;UBERON:0001004 denotes respiratory
T42 399-421 SP_7 denotes syndrome coronavirus 2
T41 423-433 SP_7 denotes SARS-CoV-2
T40 512-520 SP_7 denotes COVID-19
T39 631-636 NCBITaxon:10239 denotes viral
T38 721-725 UBERON:0007221 denotes care
T37 764-772 UBERON:0003126 denotes tracheal
T36 800-811 NCBITaxon:1 denotes individuals
T35 883-894 NCBITaxon:11118 denotes coronavirus
T34 1000-1008 SP_7 denotes COVID-19
T33 1149-1153 UBERON:0002048 denotes lung
T32 1605-1613 SP_7 denotes COVID-19
T31 1641-1652 NCBITaxon:1 denotes individuals
T30 1745-1753 CHEBI:60809;CHEBI:60809 denotes adjuvant
T29 1909-1917 SP_7 denotes COVID-19
T28 2052-2057 NCBITaxon:10239 denotes viral
T27 2217-2228 NCBITaxon:1 denotes individuals
T26 2239-2249 CHEBI:67079;CHEBI:67079 denotes anticancer
T25 2385-2393 SP_7 denotes COVID-19
T24 2564-2572 SP_7 denotes COVID-19
T23 2617-2628 NCBITaxon:11118 denotes coronavirus
T22 2712-2723 NCBITaxon:11118 denotes coronavirus
T21 2860-2868 SP_7 denotes COVID-19
T20 3036-3040 PR:000001919 denotes PD-1
T19 3041-3046 PR:000001543 denotes PD-L1
T18 3055-3061 PR:000001852 denotes CTLA-4
T17 3062-3068 GO:0000077 denotes immune
T16 3069-3079 GO:0000075 denotes checkpoint
T15 3080-3090 CHEBI:35222;CHEBI:35222 denotes inhibitors
T14 3173-3177 UBERON:0002048 denotes lung
T13 3186-3191 UBERON:0002113 denotes renal
T12 3203-3213 UBERON:0000365 denotes urothelial
T11 3226-3230 UBERON:0000033 denotes head
T10 3235-3239 UBERON:0000974 denotes neck
T9 3332-3341 NCBITaxon:2 denotes bacterial
T8 3345-3350 NCBITaxon:10239 denotes viral
T7 3568-3574 UBERON:0002405;GO:0000077 denotes immune
T6 3575-3585 GO:0000075 denotes checkpoint
T1 77-87 CHEBI:35222;CHEBI:35222 denotes inhibitors
T2 66-76 GO:0006955 denotes checkpoint
T3 59-65 UBERON:0002405;GO:0006955 denotes immune
T4 33-43 CHEBI:67079;CHEBI:67079 denotes anticancer
T5 20-28 SP_7 denotes COVID-19
T186 13649-13657 SP_7 denotes COVID-19

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 1149-1153 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T2 3173-3177 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T3 3226-3239 Body_part denotes head and neck http://purl.org/sig/ont/fma/fma280881
T4 4031-4035 Body_part denotes hand http://purl.org/sig/ont/fma/fma9712
T5 4266-4270 Body_part denotes hand http://purl.org/sig/ont/fma/fma9712
T6 4624-4628 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T7 4918-4922 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T8 5313-5317 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T9 5589-5593 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T10 6082-6092 Body_part denotes renal cell http://purl.org/sig/ont/fma/fma86785
T11 6088-6092 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T12 6290-6298 Body_part denotes Cytokine http://purl.org/sig/ont/fma/fma84050
T13 6404-6408 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T14 6449-6453 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T15 6560-6569 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T16 6688-6693 Body_part denotes organ http://purl.org/sig/ont/fma/fma67498
T17 6704-6708 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T18 6851-6859 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T19 6931-6936 Body_part denotes organ http://purl.org/sig/ont/fma/fma67498
T20 7046-7051 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T21 7178-7183 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T22 7213-7218 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T23 7319-7324 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T24 7566-7571 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T25 7586-7597 Body_part denotes lymphocytes http://purl.org/sig/ont/fma/fma62863
T26 8042-8050 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T27 9189-9197 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T28 11070-11078 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T29 11539-11548 Body_part denotes cytokines http://purl.org/sig/ont/fma/fma84050
T30 11606-11620 Body_part denotes dendritic cell http://purl.org/sig/ont/fma/fma273565
T31 11616-11620 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T32 11664-11673 Body_part denotes leukocyte http://purl.org/sig/ont/fma/fma62852
T33 11746-11750 Body_part denotes hand http://purl.org/sig/ont/fma/fma9712
T34 11797-11805 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T35 11894-11898 Body_part denotes hand http://purl.org/sig/ont/fma/fma9712
T36 12481-12489 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T37 12602-12612 Body_part denotes neutrophil http://purl.org/sig/ont/fma/fma62860
T38 12613-12617 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T39 12682-12690 Body_part denotes cytokine http://purl.org/sig/ont/fma/fma84050
T40 12726-12730 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T41 12838-12843 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T42 12983-12987 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 1149-1153 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T2 3173-3177 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T3 3226-3230 Body_part denotes head http://purl.obolibrary.org/obo/UBERON_0000033
T4 3235-3239 Body_part denotes neck http://purl.obolibrary.org/obo/UBERON_0000974
T5 4031-4035 Body_part denotes hand http://purl.obolibrary.org/obo/UBERON_0002398
T6 4266-4270 Body_part denotes hand http://purl.obolibrary.org/obo/UBERON_0002398
T7 4624-4628 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T8 4918-4922 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T9 5313-5317 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T10 5589-5593 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T11 6688-6693 Body_part denotes organ http://purl.obolibrary.org/obo/UBERON_0000062
T12 6704-6708 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T13 6931-6936 Body_part denotes organ http://purl.obolibrary.org/obo/UBERON_0000062
T14 11746-11750 Body_part denotes hand http://purl.obolibrary.org/obo/UBERON_0002398
T15 11894-11898 Body_part denotes hand http://purl.obolibrary.org/obo/UBERON_0002398
T16 12726-12730 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T17 12983-12987 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048

LitCovid_AGAC

Id Subject Object Predicate Lexical cue
p70022s18 11616-11631 CPA denotes cell maturation
p70022s24 11664-11685 MPA denotes leukocyte populations

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 20-28 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T2 124-130 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T3 208-216 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T4 358-368 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T5 374-421 Disease denotes severe acute respiratory syndrome coronavirus 2 http://purl.obolibrary.org/obo/MONDO_0100096
T6 374-407 Disease denotes severe acute respiratory syndrome http://purl.obolibrary.org/obo/MONDO_0005091
T7 423-431 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T8 512-520 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T9 631-646 Disease denotes viral infection http://purl.obolibrary.org/obo/MONDO_0005108
T10 637-646 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T11 813-819 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T12 895-904 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T13 1000-1008 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T14 1055-1061 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T15 1077-1083 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T16 1149-1160 Disease denotes lung cancer http://purl.obolibrary.org/obo/MONDO_0008903
T17 1154-1160 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T18 1211-1217 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T19 1302-1308 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T20 1343-1349 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T21 1570-1576 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T22 1605-1613 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T23 1661-1667 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T24 1798-1804 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T25 1909-1917 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T26 1935-1941 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T27 2096-2102 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T28 2385-2393 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T29 2498-2504 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T30 2564-2572 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T31 2724-2734 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T32 2860-2868 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T33 2989-2995 Disease denotes Cancer http://purl.obolibrary.org/obo/MONDO_0004992
T34 3148-3154 Disease denotes tumors http://purl.obolibrary.org/obo/MONDO_0005070
T35 3163-3171 Disease denotes melanoma http://purl.obolibrary.org/obo/MONDO_0005105
T36 3173-3184 Disease denotes lung cancer http://purl.obolibrary.org/obo/MONDO_0008903
T37 3178-3184 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T38 3186-3201 Disease denotes renal carcinoma http://purl.obolibrary.org/obo/MONDO_0005206
T39 3192-3201 Disease denotes carcinoma http://purl.obolibrary.org/obo/MONDO_0004993
T40 3226-3249 Disease denotes head and neck carcinoma http://purl.obolibrary.org/obo/MONDO_0002038
T41 3240-3249 Disease denotes carcinoma http://purl.obolibrary.org/obo/MONDO_0004993
T42 3345-3361 Disease denotes viral infections http://purl.obolibrary.org/obo/MONDO_0005108
T43 3524-3543 Disease denotes influenza infection http://purl.obolibrary.org/obo/MONDO_0005812
T44 3534-3543 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T45 3630-3636 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T46 3710-3718 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T47 3825-3833 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T48 3935-3941 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T49 4090-4096 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T50 4229-4237 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T51 4375-4383 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T52 4537-4546 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T53 4755-4766 Disease denotes pneumonitis http://purl.obolibrary.org/obo/MONDO_0043905
T54 4964-4984 Disease denotes organizing pneumonia http://purl.obolibrary.org/obo/MONDO_0015265|http://purl.obolibrary.org/obo/MONDO_0056821
T56 4975-4984 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T57 5002-5013 Disease denotes pneumonitis http://purl.obolibrary.org/obo/MONDO_0043905
T58 5091-5102 Disease denotes pneumonitis http://purl.obolibrary.org/obo/MONDO_0043905
T59 5147-5158 Disease denotes pneumonitis http://purl.obolibrary.org/obo/MONDO_0043905
T60 5313-5325 Disease denotes lung disease http://purl.obolibrary.org/obo/MONDO_0005275
T61 5420-5431 Disease denotes pneumonitis http://purl.obolibrary.org/obo/MONDO_0043905
T62 5551-5559 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T63 5842-5850 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T64 6069-6077 Disease denotes melanoma http://purl.obolibrary.org/obo/MONDO_0005105
T65 6082-6102 Disease denotes renal cell carcinoma http://purl.obolibrary.org/obo/MONDO_0005086|http://purl.obolibrary.org/obo/MONDO_0005549
T67 6093-6102 Disease denotes carcinoma http://purl.obolibrary.org/obo/MONDO_0004993
T68 6280-6288 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T69 6317-6320 Disease denotes CRS http://purl.obolibrary.org/obo/MONDO_0007399|http://purl.obolibrary.org/obo/MONDO_0017361
T71 6494-6497 Disease denotes CRS http://purl.obolibrary.org/obo/MONDO_0007399|http://purl.obolibrary.org/obo/MONDO_0017361
T73 6820-6828 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T74 6878-6913 Disease denotes acute respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0006502
T75 6884-6913 Disease denotes respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0009971
T76 6922-6944 Disease denotes multiple organ failure http://purl.obolibrary.org/obo/MONDO_0043726
T77 6978-6986 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T78 7366-7372 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T79 7446-7481 Disease denotes acute respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0006502
T80 7452-7481 Disease denotes respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0009971
T81 7485-7493 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T82 7701-7709 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T83 7807-7815 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T84 7991-7994 Disease denotes CRS http://purl.obolibrary.org/obo/MONDO_0007399|http://purl.obolibrary.org/obo/MONDO_0017361
T86 8086-8094 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T87 8239-8245 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T88 8454-8457 Disease denotes flu http://purl.obolibrary.org/obo/MONDO_0005812
T89 8621-8629 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T90 8723-8756 Disease denotes severe acute respiratory syndrome http://purl.obolibrary.org/obo/MONDO_0005091
T91 9118-9126 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T92 9330-9350 Disease denotes rheumatoid arthritis http://purl.obolibrary.org/obo/MONDO_0008383
T93 9341-9350 Disease denotes arthritis http://purl.obolibrary.org/obo/MONDO_0005578
T94 9520-9523 Disease denotes CRS http://purl.obolibrary.org/obo/MONDO_0007399|http://purl.obolibrary.org/obo/MONDO_0017361
T96 9716-9722 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T97 9944-9952 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T98 10013-10021 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T99 10024-10033 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T100 10244-10252 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T101 10362-10368 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T102 11100-11108 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T103 11111-11120 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T104 11193-11199 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T105 11307-11315 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T106 11348-11356 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T107 11446-11452 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T108 11469-11475 Disease denotes Cancer http://purl.obolibrary.org/obo/MONDO_0004992
T109 11831-11866 Disease denotes acute respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0006502
T110 11837-11866 Disease denotes respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0009971
T111 11868-11872 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T112 11931-11939 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T113 11942-11951 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T114 12109-12117 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T115 12248-12267 Disease denotes influenza infection http://purl.obolibrary.org/obo/MONDO_0005812
T116 12258-12267 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T117 12341-12350 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T118 12437-12446 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T119 12447-12462 Disease denotes virus infection http://purl.obolibrary.org/obo/MONDO_0005108
T120 12453-12462 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T121 12664-12673 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T122 12789-12799 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T123 12953-12962 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T124 13073-13077 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T125 13139-13154 Disease denotes viral infection http://purl.obolibrary.org/obo/MONDO_0005108
T126 13145-13154 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T127 13213-13222 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T128 13304-13312 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T129 13379-13394 Disease denotes viral infection http://purl.obolibrary.org/obo/MONDO_0005108
T130 13385-13394 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T131 13409-13413 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T132 13443-13452 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T133 13579-13585 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T134 13649-13657 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T135 13824-13830 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T136 13981-13989 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T137 14022-14028 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 96-101 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T2 143-145 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T3 190-195 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T4 227-228 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T5 607-608 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T6 839-840 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T7 935-936 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T8 995-999 http://purl.obolibrary.org/obo/CLO_0053133 denotes 1590
T9 1035-1037 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T10 1042-1043 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T11 1149-1153 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T12 1149-1153 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T13 1240-1241 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T14 1408-1409 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T15 1508-1509 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T16 1588-1589 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T17 1672-1673 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T18 2446-2447 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T19 2804-2805 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T20 3041-3046 http://purl.obolibrary.org/obo/CLO_0008407 denotes PD-L1
T21 3055-3061 http://purl.obolibrary.org/obo/PR_000001852 denotes CTLA-4
T22 3173-3177 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T23 3173-3177 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T24 3226-3230 http://purl.obolibrary.org/obo/UBERON_0000033 denotes head
T25 3226-3230 http://www.ebi.ac.uk/efo/EFO_0000964 denotes head
T26 3235-3239 http://www.ebi.ac.uk/efo/EFO_0000967 denotes neck
T27 3261-3262 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T28 3362-3365 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T29 3928-3934 http://purl.obolibrary.org/obo/CLO_0001658 denotes active
T30 4019-4021 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T31 4602-4607 http://purl.obolibrary.org/obo/CLO_0008407 denotes PD-L1
T32 4624-4628 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T33 4624-4628 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T34 4801-4806 http://purl.obolibrary.org/obo/CLO_0008407 denotes PD-L1
T35 4838-4844 http://purl.obolibrary.org/obo/PR_000001852 denotes CTLA-4
T36 4918-4922 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T37 4918-4922 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T38 4964-4974 http://purl.obolibrary.org/obo/OBI_0000245 denotes organizing
T39 5028-5029 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T40 5177-5179 http://purl.obolibrary.org/obo/CLO_0051456 denotes AE
T41 5201-5206 http://purl.obolibrary.org/obo/CLO_0008407 denotes PD-L1
T42 5241-5243 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T43 5313-5317 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T44 5313-5317 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T45 5390-5391 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T46 5589-5593 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T47 5589-5593 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T48 5757-5758 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T49 5994-5997 http://purl.obolibrary.org/obo/PR_000001343 denotes aim
T50 6088-6092 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T51 6217-6218 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T52 6325-6326 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T53 6402-6408 http://purl.obolibrary.org/obo/CL_0000084 denotes T cell
T54 6443-6446 http://purl.obolibrary.org/obo/CLO_0002199 denotes CAR
T55 6447-6453 http://purl.obolibrary.org/obo/CL_0000084 denotes T cell
T56 6625-6635 http://purl.obolibrary.org/obo/CLO_0001658 denotes activation
T57 6688-6693 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organ
T58 6704-6708 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T59 6704-6708 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T60 6931-6936 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organ
T61 7032-7035 http://purl.obolibrary.org/obo/PR_000001004 denotes CD4
T62 7040-7043 http://purl.obolibrary.org/obo/CLO_0053438 denotes CD8
T63 7044-7051 http://purl.obolibrary.org/obo/CL_0000084 denotes T cells
T64 7172-7175 http://purl.obolibrary.org/obo/PR_000001004 denotes CD4
T65 7176-7183 http://purl.obolibrary.org/obo/CL_0000084 denotes T cells
T66 7184-7187 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T67 7207-7210 http://purl.obolibrary.org/obo/CLO_0053438 denotes CD8
T68 7211-7218 http://purl.obolibrary.org/obo/CL_0000084 denotes T cells
T69 7317-7324 http://purl.obolibrary.org/obo/CL_0000084 denotes T cells
T70 7566-7571 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T71 7770-7771 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T72 7851-7852 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T73 7998-7999 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T74 8193-8194 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T75 8768-8770 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T76 9154-9155 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T77 9168-9177 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes humanized
T78 9234-9239 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T79 9270-9276 http://purl.obolibrary.org/obo/SO_0000418 denotes signal
T80 9369-9372 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T81 9653-9654 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T82 9977-9978 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T83 10080-10081 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T84 10162-10163 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T85 10204-10205 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T86 10661-10662 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T87 10855-10856 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T88 10997-10998 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T89 11254-11255 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T90 11588-11595 http://purl.obolibrary.org/obo/SO_0000418 denotes signals
T91 11606-11620 http://purl.obolibrary.org/obo/CL_0000451 denotes dendritic cell
T92 11960-11961 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T93 12431-12436 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T94 12447-12452 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T95 12588-12593 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T96 12613-12617 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T97 12726-12730 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T98 12726-12730 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T99 12810-12815 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T100 12832-12835 http://purl.obolibrary.org/obo/PR_000001004 denotes CD4
T101 12836-12843 http://purl.obolibrary.org/obo/CL_0000084 denotes T cells
T102 12854-12859 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T103 12983-12987 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T104 12983-12987 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 77-87 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T2 183-189 Chemical denotes corona http://purl.obolibrary.org/obo/CHEBI_37409
T3 1745-1753 Chemical denotes adjuvant http://purl.obolibrary.org/obo/CHEBI_60809
T4 3036-3038 Chemical denotes PD http://purl.obolibrary.org/obo/CHEBI_74756
T5 3041-3043 Chemical denotes PD http://purl.obolibrary.org/obo/CHEBI_74756
T6 3080-3090 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T7 4597-4599 Chemical denotes PD http://purl.obolibrary.org/obo/CHEBI_74756
T8 4602-4604 Chemical denotes PD http://purl.obolibrary.org/obo/CHEBI_74756
T9 4796-4798 Chemical denotes PD http://purl.obolibrary.org/obo/CHEBI_74756
T10 4801-4803 Chemical denotes PD http://purl.obolibrary.org/obo/CHEBI_74756
T11 4850-4852 Chemical denotes PD http://purl.obolibrary.org/obo/CHEBI_74756
T12 5177-5179 Chemical denotes AE http://purl.obolibrary.org/obo/CHEBI_61565
T13 5196-5198 Chemical denotes PD http://purl.obolibrary.org/obo/CHEBI_74756
T14 5201-5203 Chemical denotes PD http://purl.obolibrary.org/obo/CHEBI_74756
T15 5207-5216 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222
T16 6114-6122 Chemical denotes adjuvant http://purl.obolibrary.org/obo/CHEBI_60809
T17 6476-6478 Chemical denotes PD http://purl.obolibrary.org/obo/CHEBI_74756
T18 6537-6539 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T20 8542-8553 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T21 8659-8668 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T22 8932-8947 Chemical denotes antiviral drugs http://purl.obolibrary.org/obo/CHEBI_36044
T23 8932-8941 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T24 8942-8947 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T25 8951-8970 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T26 8951-8960 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T27 8961-8970 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T28 8981-8990 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T29 8994-9004 Chemical denotes remdesivir http://purl.obolibrary.org/obo/CHEBI_145994
T30 9039-9050 Chemical denotes chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T31 9055-9073 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T32 9205-9216 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T33 9240-9242 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T35 9696-9707 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T36 9771-9773 Chemical denotes PD http://purl.obolibrary.org/obo/CHEBI_74756
T37 9905-9916 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T38 12093-12104 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T39 12306-12308 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T41 12555-12557 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T43 12760-12762 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T45 12922-12924 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T47 13085-13087 Chemical denotes IL http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072
T49 13263-13274 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 631-646 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infection
T2 3345-3361 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infections
T3 3719-3731 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T4 6264-6276 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T5 7816-7828 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T6 8095-8107 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T7 9270-9289 http://purl.obolibrary.org/obo/GO_0007165 denotes signal transduction
T8 9277-9289 http://purl.obolibrary.org/obo/GO_0009293 denotes transduction
T9 9478-9499 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory response
T10 9599-9620 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammatory response
T11 10308-10323 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T12 11616-11631 http://purl.obolibrary.org/obo/GO_0048469 denotes cell maturation
T13 12613-12623 http://purl.obolibrary.org/obo/GO_0008219 denotes cell death
T14 12825-12831 http://purl.obolibrary.org/obo/GO_0007613 denotes memory
T15 13139-13154 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infection
T16 13170-13182 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis
T17 13379-13394 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infection

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 124-130 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T2 813-819 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T3 1055-1061 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T4 1077-1083 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T5 1149-1160 Phenotype denotes lung cancer http://purl.obolibrary.org/obo/HP_0100526
T6 1211-1217 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T7 1302-1308 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T8 1343-1349 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T9 1570-1576 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T10 1661-1667 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T11 1798-1804 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T12 1935-1941 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T13 2096-2102 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T14 2498-2504 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T15 2989-2995 Phenotype denotes Cancer http://purl.obolibrary.org/obo/HP_0002664
T16 3163-3171 Phenotype denotes melanoma http://purl.obolibrary.org/obo/HP_0002861
T17 3173-3184 Phenotype denotes lung cancer http://purl.obolibrary.org/obo/HP_0100526
T18 3186-3201 Phenotype denotes renal carcinoma http://purl.obolibrary.org/obo/HP_0005584
T19 3240-3249 Phenotype denotes carcinoma http://purl.obolibrary.org/obo/HP_0030731
T20 3630-3636 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T21 3935-3941 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T22 4090-4096 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T23 4537-4546 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T24 4975-4984 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T25 5078-5102 Phenotype denotes interstitial pneumonitis http://purl.obolibrary.org/obo/HP_0006515
T26 5313-5325 Phenotype denotes lung disease http://purl.obolibrary.org/obo/HP_0002088
T27 6069-6077 Phenotype denotes melanoma http://purl.obolibrary.org/obo/HP_0002861
T28 6082-6102 Phenotype denotes renal cell carcinoma http://purl.obolibrary.org/obo/HP_0005584
T29 6290-6315 Phenotype denotes Cytokine-release syndrome http://purl.obolibrary.org/obo/HP_0033041
T30 6650-6655 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T31 6657-6664 Phenotype denotes malaise http://purl.obolibrary.org/obo/HP_0012378
T32 6669-6677 Phenotype denotes myalgias http://purl.obolibrary.org/obo/HP_0003326
T33 6851-6865 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T34 6884-6904 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T35 7452-7472 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T36 8042-8056 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T37 8239-8245 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T38 9330-9350 Phenotype denotes rheumatoid arthritis http://purl.obolibrary.org/obo/HP_0001370
T39 9716-9722 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T40 10458-10478 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T41 11070-11084 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T42 11193-11199 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T43 11446-11452 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T44 11469-11475 Phenotype denotes Cancer http://purl.obolibrary.org/obo/HP_0002664
T45 11797-11811 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T46 11837-11857 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T47 12682-12696 Phenotype denotes cytokine storm http://purl.obolibrary.org/obo/HP_0033041
T48 13579-13585 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T49 13824-13830 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T50 14022-14028 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-87 Sentence denotes Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors
T2 89-139 Sentence denotes Corona virus disease-19 pandemic & cancer patients
T3 140-242 Sentence denotes On 11 March, the WHO formally declared the corona virus disease-19 (COVID-19) outbreak a pandemic [1].
T4 243-511 Sentence denotes After the first cluster of cases emerged from Wuhan, in China, at the end of 2019, up today almost 287000 cases of infections from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been diagnosed across all five continents in the last few months [2,3].
T5 512-788 Sentence denotes COVID-19 morbidity and mortality have been linked to elderly age and comorbidities, leading to a poorer outcome to the viral infection for frail patients and more often resulting in hospitalization, intensive care unit admittance and need for invasive tracheal intubation [4].
T6 789-934 Sentence denotes Among such individuals, cancer patients represent a large subgroup at high risk of developing coronavirus infection and its severe complications.
T7 935-1196 Sentence denotes A recent nationwide analysis in China demonstrated that, of 1590 COVID-19 cases from 575 hospitals, 18 had a history of cancer (1 vs 0.29% of cancer incidence in the overall Chinese population, respectively), with lung cancer as the most frequent diagnosis [5].
T8 1197-1332 Sentence denotes Patients with cancer were observed to have a higher risk of severe events compared with patients without cancer (39 vs 8%; p = 0.0003).
T9 1333-1489 Sentence denotes Moreover, cancer patients who underwent recent chemotherapy or surgery had a higher risk of clinically severe events than did those not receiving treatment.
T10 1490-1668 Sentence denotes With the limit of a small sample size, the authors concluded that patients with cancer might have a higher risk of COVID-19, and poorer outcomes, than individuals without cancer.
T11 1669-1826 Sentence denotes As a consequence, they recommended to consider an intentional postponing of adjuvant chemotherapy or elective surgery for stable cancer in endemic areas [5].
T12 1827-2070 Sentence denotes Nevertheless, as subsequently highlighted by other authors, the true incidence of COVID-19 in patients with cancer would be more informative in assessing whether such patients have an increased risk (and morbidity) from this viral illness [6].
T13 2071-2264 Sentence denotes Furthermore, the limited cancer patient population described in this first report from the literature, was curiously characterized by the lack of individuals receiving anticancer immunotherapy.
T14 2265-2394 Sentence denotes Indeed, only chemotherapy and surgery were cited among treatments received by patients in the month prior to developing COVID-19.
T15 2395-2638 Sentence denotes Maybe, this could simply be due to the casualty of a small sample, or otherwise, it could suggest that cancer patients receiving immunotherapy are less prone to develop COVID-19 or to be admitted in hospital due to severe coronavirus symptoms.
T16 2639-2988 Sentence denotes Currently, we are aware of the probably higher incidence of misdiagnosed coronavirus infections compared with that reported and updated every day; it is likely that a great portion of healthy and young population develop COVID-19 with mild symptoms, not requiring hospital admittance and thus escaping the laboratory confirmation of the disease [7].
T17 2989-3298 Sentence denotes Cancer patients undergoing treatment with anti-PD-1/PD-L1 or anti-CTLA-4 immune checkpoint inhibitors (ICI) currently used in everyday practice to treat solid tumors such as melanoma, lung cancer, renal carcinoma, urothelial cancers and head and neck carcinoma constitute a growing oncological population [8].
T18 3299-3388 Sentence denotes Their specific susceptibility to bacterial or viral infections has not been investigated.
T19 3389-3677 Sentence denotes Considering that immunotherapy with ICI is able to restore the cellular immunocompetence, as we previously suggested in the context of influenza infection, the patient undergoing immune checkpoint blockade could be more immunocompetent than cancer patients undergoing chemotherapy [9,10].
T20 3679-3760 Sentence denotes Potential interference between COVID-19 pathogenesis & immune checkpoint blockade
T21 3761-4023 Sentence denotes In the recent weeks, in the countries heavily interested by the COVID-19 outbreak, such as Italy, the scientific associations recommended the prudential postponing of active cancer treatments, especially for stable patients not needing urgent interventions [11].
T22 4024-4252 Sentence denotes On one hand, this recommendation could be reasonable for advanced cancer patients receiving chemotherapy, with the risk of hematological toxicity and of worsening an immunosuppressed status, thus favoring COVID-19 morbidity [5].
T23 4253-4432 Sentence denotes On the other hand, some oncologists are even currently wondering about the risk of administering ICI in the middle of the COVID-19 outbreak, essentially due to two major concerns.
T24 4433-4615 Sentence denotes The first seems to be represented by the potential overlap between the coronavirus-related interstitial pneumonia and the possible pneumological toxicity from anti-PD-1/PD-L1 agents.
T25 4616-4712 Sentence denotes Even if lung toxicity is not the most frequent adverse event of ICI, it can be life threatening.
T26 4713-4880 Sentence denotes The overall incidence rate of ICI-related pneumonitis ranges from 2.5–5% with anti-PD-1/PD-L1 monotherapy to 7–10% with anti-CTLA-4/anti-PD-1 combination therapy [12].
T27 4881-5108 Sentence denotes The dominant radiological pattern of lung immune-related adverse events (irAEs) is organizing pneumonia, but ICI-related pneumonitis could exhibit a variety of patterns, also including nonspecific interstitial pneumonitis [13].
T28 5109-5284 Sentence denotes Despite being rarer than other irAEs, pneumonitis is the most fatal AE associated with PD-1/PD-L1 inhibitor therapy, accounting for 35% of treatment-related toxic deaths [14].
T29 5285-5560 Sentence denotes Considering that underlying lung disease, particularly including interstitial pneumopathy, is considered a risk factor for ICI-related pneumonitis, it could be reasonable taking into account the risk of treating patients while they are developing an initial form of COVID-19.
T30 5561-5658 Sentence denotes The synergy between the two lung injuries, despite only hypothetical, cannot be surely ruled out.
T31 5659-5929 Sentence denotes Nevertheless, such an epidemiological coincidence should not prevent the oncologist from offering a potentially effective and often well-tolerated treatment even in the middle of the COVID-19 outbreak, since the duration of the pandemic is still currently unpredictable.
T32 5930-6170 Sentence denotes This is true in particular considering the potentially curative aim of ICI treatment in the context of highly responsive diseases, such as melanoma and renal cell carcinoma and in the adjuvant setting even more than in the advanced disease.
T33 6171-6289 Sentence denotes The second concern seems to be represented by a possible negative interference of ICI in the pathogenesis of COVID-19.
T34 6290-6493 Sentence denotes Cytokine-release syndrome (CRS) is a phenomenon of immune hyperactivation typically described in the setting of T cell-engaging immunotherapy, including CAR-T cell therapy but also anti-PD-1 agents [15].
T35 6494-6727 Sentence denotes CRS is characterized by elevated levels of IL-6, IFN- γ and other cytokines, provoking consequences and symptoms related to immune activation, ranging from fever, malaise and myalgias to severe organ toxicity, lung failure and death.
T36 6728-6950 Sentence denotes In parallel, one of the most important mechanism underlying the deterioration of disease in COVID-19 is represented by the cytokine storm, leading to acute respiratory distress syndrome or even multiple organ failure [16].
T37 6951-7091 Sentence denotes The cytometric analyses of COVID-19 patients showed reduced counts of peripheral CD4 and CD8 T cells, while their status was hyperactivated.
T38 7092-7393 Sentence denotes In addition, an increased concentration of highly proinflammatory CCR6+ Th17 in CD4 T cells has been reported, and CD8 T cells were found to harbor high concentrations of cytotoxic granules, suggesting that overactivation of T cells tends to contribute to the severe immune injury of the disease [17].
T39 7394-7724 Sentence denotes Moreover, the pathological findings associated with acute respiratory distress syndrome in COVID-19 showed abundant interstitial mononuclear inflammatory infiltrate in the lungs, dominated by lymphocytes, once again implying that the immune hyperactivation mechanisms are at least partially accountable for COVID-19 severity [17].
T40 7725-7914 Sentence denotes Considering these aspects, the hypothesis of a synergy between ICI mechanisms and COVID-19 pathogenesis, both contributing to a counter-producing immune hyperactivation, cannot be excluded.
T41 7915-8216 Sentence denotes In spite of this fascinating rationale, we should remember that ICI-induced CRS is a quite rare phenomenon as well as that the cytokine storm is not an early event in the COVID-19 pathogenesis, indeed characterizing the late phase of its most severe manifestation, occurring in a minority of patients.
T42 8217-8318 Sentence denotes It is not likely that cancer patients are still receiving ICI during this phase of the viral illness.
T43 8319-8514 Sentence denotes Obviously, in the current pandemic scenario, careful attention should be dedicated in delaying treatment for those patients presenting flu-like symptoms at the time of the intended ICI treatment.
T44 8516-8585 Sentence denotes Therapeutic implications: tocilizumab & the risk of hasty conclusions
T45 8586-8772 Sentence denotes Since its first outbreak in China, COVID-19 was empirically treated with antiviral therapy, first employing agents already used in prior severe acute respiratory syndrome epidemics [18].
T46 8773-9079 Sentence denotes Then, several randomized clinical trials were initiated in China and more recently in Italy, investigating different treatment options, varying from classical antiviral drugs as lopinavir/ritonavir, to newer antiviral as remdesivir, to unconventional agents such as chloroquine and hydroxychloroquine [19].
T47 9080-9295 Sentence denotes The latest treatment frontier against COVID-19 seems to be represented by a recombinant humanized monoclonal antibody, named tocilizumab, which binds the human IL-6 receptor, inhibiting its signal transduction [20].
T48 9296-9529 Sentence denotes Tocilizumab is currently used for rheumatoid arthritis, but its efficacy has been demonstrated also against ICI-induced irAEs, starting from the rationale of an ICI-induced systemic inflammatory response syndrome similar to CRS [21].
T49 9530-9791 Sentence denotes Moreover, along with the improvement in symptoms related to systemic inflammatory response syndrome, some authors reported a clinical improvement in other irAEs with tocilizumab used in cancer patients with immune-related toxicity from anti-PD-1 agents [21,22].
T50 9792-9864 Sentence denotes With these premises, the risk of hasty conclusions is around the corner.
T51 9865-10130 Sentence denotes In fact, one can argue that the alleged tocilizumab efficacy both for treating COVID-19 and irAEs might suggest a potentially increased danger from SARS-CoV-2 infection for ICI-treated patients, maybe hypothesizing a synergy in the promotion of the viral morbidity.
T52 10131-10186 Sentence denotes Nevertheless, this is probably a thoughtless deduction.
T53 10187-10221 Sentence denotes First, it can be a matter of time.
T54 10222-10484 Sentence denotes The time at which the COVID-19 patient develops the pathologic hyperactivation of the immune response, eventually contributing to the final injury, is probably in the late phase of the disease manifestation, occurring together with the respiratory distress [17].
T55 10485-10654 Sentence denotes Furthermore, the time matters also in the case of ICI therapy, since the majority of patients develop irAEs within the first 6 months from the first administration [12].
T56 10655-10831 Sentence denotes Thus, a certain caution for ICI administration during the pandemics could be applied mostly for those patients needing therapy initiation or in their first months of treatment.
T57 10832-10875 Sentence denotes Second, it is probably a matter of patient.
T58 10876-10987 Sentence denotes Patients more prone to developing immune hyperactivation are probably those more likely to respond to ICI [23].
T59 10988-11121 Sentence denotes There is a possibility that such patients would be also more prone to fall in the cytokine storm in the case of SARS-CoV-2 infection.
T60 11122-11282 Sentence denotes Nevertheless, these patients do not correspond to the average advanced cancer patient, who is supposed to be immunosuppressed, with a blunted immune status [6].
T61 11283-11468 Sentence denotes The epidemiology of the COVID-19 observed up today suggests that SARS-CoV-2 tends to infect more frequently the frail patient populations, such as the elderly and cancer patients [4,5].
T62 11469-11690 Sentence denotes Cancer is usually associated with overexpression of immunosuppressive cytokines, suppression of proinflammatory danger signals, impaired dendritic cell maturation, and enhanced immunosuppressive leukocyte populations [6].
T63 11691-12069 Sentence denotes Since ICI can restore the immune-competence, if on one hand it can be paradoxically needed to develop the cytokine storm characterizing the acute respiratory distress syndrome (ARDS) phase, on the other hand the epidemiological features of SARS-CoV-2 infection lay for a lower probability to affect these patients compared with their chemo-treated immune-suppressed counterpart.
T64 12070-12268 Sentence denotes Third, the efficacy of tocilizumab for COVID-19 is still under investigation, with still unexplored backstage and with uncomfortable upstream evidence coming from the setting of influenza infection.
T65 12269-12514 Sentence denotes Despite clinical studies associating IL-6 with high disease severity in influenza-infected patients and its levels correlated directly with symptom occurrence in human influenza virus infection, the role of this cytokine is still ambiguous [24].
T66 12515-12746 Sentence denotes It was demonstrated in mice models that IL-6 is essential for preventing virus-induced neutrophil cell death and H1N1-associated mortality, limiting influenza-induced cytokine storm and protecting against fatal lung pathology [25].
T67 12747-12993 Sentence denotes Furthermore, IL-6 is crucial in secondary infections to recall virus-specific memory CD4 T cells, favoring virus clearance and host survival, as supported by the inability of IL-6 deficient mice to control influenza viral titers in the lung [25].
T68 12994-13541 Sentence denotes Such preclinical evidence suggests that, despite probably being harmful in the ARDS phase, IL-6 role could be crucial, in the early phase of the viral infection, to defuse the pathogenesis of severe and lethal forms of influenza. Thus, hoping for positive results from tocilizumab randomized clinical trial on COVID-19 patients, we could only argue about the evident diversity of this viral infection from previous SARS outbreaks and even more from influenza epidemics, probably both in terms of clinical features and of pathogenetic implications.
T69 13543-13553 Sentence denotes Conclusion
T70 13554-13883 Sentence denotes Clinical decisions about cancer patients deserving immunotherapy in the current context of the COVID-19 pandemic should be characterized by separated reflections, avoiding generalizations and remembering their deeply different immunological status compared with that of cancer patients undergoing chemotherapy or targeted agents.
T71 13884-14258 Sentence denotes In the end, beyond any charming scientific speculations, it is unfortunately likely that in this COVID-19 pandemic, the greatest risk for cancer patients is the unavailability of the usually high-level medical services, since all our hospital resources, in terms of structures, tools and healthcare professionals, are currently strongly dedicated to the outbreak management.
T72 14260-14302 Sentence denotes Financial & competing interests disclosure
T73 14303-14550 Sentence denotes The author received research funding by Roche, Pfizer, Seqirus, AstraZeneca, Bristol-Myers Squibb, Novartis and Sanofi; she also received honoraria for advisory role and as speaker at scientific events by Bristol-Myers Squibb, Novartis and Pfizer.
T74 14551-14623 Sentence denotes No writing assistance was utilized in the production of this manuscript.

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1 20-28 Disease denotes COVID-19 MESH:C000657245
4 89-112 Disease denotes Corona virus disease-19 MESH:C000657245
5 124-130 Disease denotes cancer MESH:D009369
11 374-421 Species denotes severe acute respiratory syndrome coronavirus 2 Tax:2697049
12 423-433 Species denotes SARS-CoV-2 Tax:2697049
13 183-206 Disease denotes corona virus disease-19 MESH:C000657245
14 208-216 Disease denotes COVID-19 MESH:C000657245
15 358-368 Disease denotes infections MESH:D007239
38 657-665 Species denotes patients Tax:9606
39 820-828 Species denotes patients Tax:9606
40 1197-1205 Species denotes Patients Tax:9606
41 1285-1293 Species denotes patients Tax:9606
42 1350-1358 Species denotes patients Tax:9606
43 1556-1564 Species denotes patients Tax:9606
44 512-520 Disease denotes COVID-19 MESH:C000657245
45 535-544 Disease denotes mortality MESH:D003643
46 631-646 Disease denotes viral infection MESH:D001102
47 813-819 Disease denotes cancer MESH:D009369
48 883-904 Disease denotes coronavirus infection MESH:D018352
49 1000-1008 Disease denotes COVID-19 MESH:C000657245
50 1055-1061 Disease denotes cancer MESH:D009369
51 1077-1083 Disease denotes cancer MESH:D009369
52 1149-1160 Disease denotes lung cancer MESH:D008175
53 1211-1217 Disease denotes cancer MESH:D009369
54 1302-1308 Disease denotes cancer MESH:D009369
55 1343-1349 Disease denotes cancer MESH:D009369
56 1570-1576 Disease denotes cancer MESH:D009369
57 1605-1613 Disease denotes COVID-19 MESH:C000657245
58 1661-1667 Disease denotes cancer MESH:D009369
59 1798-1804 Disease denotes cancer MESH:D009369
92 3036-3040 Gene denotes PD-1 Gene:5133
93 3041-3046 Gene denotes PD-L1 Gene:29126
94 3055-3061 Gene denotes CTLA-4 Gene:1493
95 1921-1929 Species denotes patients Tax:9606
96 1994-2002 Species denotes patients Tax:9606
97 2103-2110 Species denotes patient Tax:9606
98 2343-2351 Species denotes patients Tax:9606
99 2505-2513 Species denotes patients Tax:9606
100 2996-3004 Species denotes patients Tax:9606
101 3549-3556 Species denotes patient Tax:9606
102 3637-3645 Species denotes patients Tax:9606
103 3524-3533 Species denotes influenza Tax:11309
104 1909-1917 Disease denotes COVID-19 MESH:C000657245
105 1935-1941 Disease denotes cancer MESH:D009369
106 2052-2065 Disease denotes viral illness
107 2096-2102 Disease denotes cancer MESH:D009369
108 2385-2393 Disease denotes COVID-19 MESH:C000657245
109 2498-2504 Disease denotes cancer MESH:D009369
110 2564-2572 Disease denotes COVID-19 MESH:C000657245
111 2617-2637 Disease denotes coronavirus symptoms MESH:D004421
112 2712-2734 Disease denotes coronavirus infections MESH:D018352
113 2860-2868 Disease denotes COVID-19 MESH:C000657245
114 2989-2995 Disease denotes Cancer MESH:D009369
115 3148-3154 Disease denotes tumors MESH:D009369
116 3163-3171 Disease denotes melanoma MESH:D008545
117 3173-3184 Disease denotes lung cancer MESH:D008175
118 3186-3201 Disease denotes renal carcinoma MESH:C538614
119 3203-3221 Disease denotes urothelial cancers MESH:D014523
120 3226-3249 Disease denotes head and neck carcinoma MESH:D006258
121 3345-3361 Disease denotes viral infections MESH:D001102
122 3534-3543 Disease denotes infection MESH:D007239
123 3630-3636 Disease denotes cancer MESH:D009369
125 3710-3718 Disease denotes COVID-19 MESH:C000657245
134 3976-3984 Species denotes patients Tax:9606
135 4097-4105 Species denotes patients Tax:9606
136 3825-3833 Disease denotes COVID-19 MESH:C000657245
137 3935-3941 Disease denotes cancer MESH:D009369
138 4090-4096 Disease denotes cancer MESH:D009369
139 4147-4169 Disease denotes hematological toxicity MESH:D006402
140 4229-4237 Disease denotes COVID-19 MESH:C000657245
141 4375-4383 Disease denotes COVID-19 MESH:C000657245
168 4597-4601 Gene denotes PD-1 Gene:5133
169 4602-4607 Gene denotes PD-L1 Gene:29126
170 4796-4800 Gene denotes PD-1 Gene:5133
171 4801-4806 Gene denotes PD-L1 Gene:29126
172 4838-4844 Gene denotes CTLA-4 Gene:1493
173 5196-5200 Gene denotes PD-1 Gene:5133
174 5201-5206 Gene denotes PD-L1 Gene:29126
175 4850-4854 Gene denotes PD-1 Gene:5133
176 4504-4515 Species denotes coronavirus Tax:11118
177 5497-5505 Species denotes patients Tax:9606
178 4537-4546 Disease denotes pneumonia MESH:D011014
179 4564-4586 Disease denotes pneumological toxicity MESH:D064420
180 4624-4637 Disease denotes lung toxicity MESH:D008171
181 4755-4766 Disease denotes pneumonitis MESH:D011014
182 4975-4984 Disease denotes pneumonia MESH:D011014
183 5002-5013 Disease denotes pneumonitis MESH:D011014
184 5078-5102 Disease denotes interstitial pneumonitis MESH:D017563
185 5147-5158 Disease denotes pneumonitis MESH:D011014
186 5272-5278 Disease denotes deaths MESH:D003643
187 5313-5325 Disease denotes lung disease MESH:D008171
188 5363-5374 Disease denotes pneumopathy MESH:C535590
189 5420-5431 Disease denotes pneumonitis MESH:D011014
190 5551-5559 Disease denotes COVID-19 MESH:C000657245
191 5589-5602 Disease denotes lung injuries MESH:D055370
192 5842-5850 Disease denotes COVID-19 MESH:C000657245
193 6069-6102 Disease denotes melanoma and renal cell carcinoma MESH:C538614
220 6476-6480 Gene denotes PD-1 Gene:5133
221 6537-6541 Gene denotes IL-6 Gene:3569
222 6543-6549 Gene denotes IFN- γ Gene:3458
223 7032-7035 Gene denotes CD4 Gene:920
224 7040-7043 Gene denotes CD8 Gene:925
225 7158-7162 Gene denotes CCR6 Gene:1235
226 7172-7175 Gene denotes CD4 Gene:920
227 7207-7210 Gene denotes CD8 Gene:925
228 6494-6497 Gene denotes CRS Gene:7291
229 6317-6320 Gene denotes CRS Gene:7291
230 6987-6995 Species denotes patients Tax:9606
231 6280-6288 Disease denotes COVID-19 MESH:C000657245
232 6650-6655 Disease denotes fever MESH:D005334
233 6657-6677 Disease denotes malaise and myalgias MESH:D063806
234 6694-6702 Disease denotes toxicity MESH:D064420
235 6704-6716 Disease denotes lung failure MESH:D012131
236 6721-6726 Disease denotes death MESH:D003643
237 6820-6828 Disease denotes COVID-19 MESH:C000657245
238 6878-6913 Disease denotes acute respiratory distress syndrome MESH:D012128
239 6922-6944 Disease denotes multiple organ failure MESH:D009102
240 6978-6986 Disease denotes COVID-19 MESH:C000657245
241 7366-7387 Disease denotes injury of the disease MESH:D004194
242 7446-7481 Disease denotes acute respiratory distress syndrome MESH:D012128
243 7485-7493 Disease denotes COVID-19 MESH:C000657245
244 7701-7709 Disease denotes COVID-19 MESH:C000657245
245 7807-7815 Disease denotes COVID-19 MESH:C000657245
253 7991-7994 Gene denotes CRS Gene:7291
254 8207-8215 Species denotes patients Tax:9606
255 8246-8254 Species denotes patients Tax:9606
256 8434-8442 Species denotes patients Tax:9606
257 8086-8094 Disease denotes COVID-19 MESH:C000657245
258 8239-8245 Disease denotes cancer MESH:D009369
259 8304-8317 Disease denotes viral illness
261 8542-8553 Chemical denotes tocilizumab MESH:C502936
279 9771-9775 Gene denotes PD-1 Gene:5133
280 9520-9523 Gene denotes CRS Gene:7291
281 9234-9239 Species denotes human Tax:9606
282 9723-9731 Species denotes patients Tax:9606
283 8951-8970 Chemical denotes lopinavir/ritonavir MESH:C558899
284 8994-9004 Chemical denotes remdesivir MESH:C000606551
285 9039-9050 Chemical denotes chloroquine MESH:D002738
286 9055-9073 Chemical denotes hydroxychloroquine MESH:D006886
287 9205-9216 Chemical denotes tocilizumab MESH:C502936
288 9296-9307 Chemical denotes Tocilizumab MESH:C502936
289 9696-9707 Chemical denotes tocilizumab MESH:C502936
290 8621-8629 Disease denotes COVID-19 MESH:C000657245
291 8730-8756 Disease denotes acute respiratory syndrome MESH:D012120
292 9118-9126 Disease denotes COVID-19 MESH:C000657245
293 9330-9350 Disease denotes rheumatoid arthritis MESH:D001172
294 9716-9722 Disease denotes cancer MESH:D009369
295 9752-9760 Disease denotes toxicity MESH:D064420
300 10050-10058 Species denotes patients Tax:9606
301 9905-9916 Chemical denotes tocilizumab MESH:C502936
302 9944-9952 Disease denotes COVID-19 MESH:C000657245
303 10018-10033 Disease denotes CoV-2 infection MESH:C000657245
309 10253-10260 Species denotes patient Tax:9606
310 10570-10578 Species denotes patients Tax:9606
311 10757-10765 Species denotes patients Tax:9606
312 10244-10252 Disease denotes COVID-19 MESH:C000657245
313 10458-10478 Disease denotes respiratory distress MESH:D012128
332 10867-10874 Species denotes patient Tax:9606
333 10876-10884 Species denotes Patients Tax:9606
334 11021-11029 Species denotes patients Tax:9606
335 11142-11150 Species denotes patients Tax:9606
336 11200-11207 Species denotes patient Tax:9606
337 11348-11358 Species denotes SARS-CoV-2 Tax:2697049
338 11401-11408 Species denotes patient Tax:9606
339 11453-11461 Species denotes patients Tax:9606
340 11996-12004 Species denotes patients Tax:9606
341 11100-11120 Disease denotes SARS-CoV-2 infection MESH:C000657245
342 11193-11199 Disease denotes cancer MESH:D009369
343 11307-11315 Disease denotes COVID-19 MESH:C000657245
344 11446-11452 Disease denotes cancer MESH:D009369
345 11469-11475 Disease denotes Cancer MESH:D009369
346 11597-11615 Disease denotes impaired dendritic MESH:D007635
347 11831-11866 Disease denotes acute respiratory distress syndrome MESH:D012128
348 11868-11872 Disease denotes ARDS MESH:D012128
349 11931-11951 Disease denotes SARS-CoV-2 infection MESH:C000657245
381 12306-12310 Gene denotes IL-6 Gene:3569
382 12555-12559 Gene denotes IL-6 Gene:16193
383 12760-12764 Gene denotes IL-6 Gene:16193
384 12832-12835 Gene denotes CD4 Gene:12504
385 12922-12926 Gene denotes IL-6 Gene:16193
386 13085-13089 Gene denotes IL-6 Gene:3569
387 12360-12368 Species denotes patients Tax:9606
388 12431-12436 Species denotes human Tax:9606
389 12538-12542 Species denotes mice Tax:10090
390 12628-12632 Species denotes H1N1 Tax:114727
391 12937-12941 Species denotes mice Tax:10090
392 13313-13321 Species denotes patients Tax:9606
393 12248-12257 Species denotes influenza Tax:11309
394 12341-12350 Species denotes influenza Tax:11309
395 12664-12673 Species denotes influenza Tax:11309
396 12953-12962 Species denotes influenza Tax:11309
397 13213-13222 Species denotes influenza Tax:11309
398 13443-13452 Species denotes influenza Tax:11309
399 12093-12104 Chemical denotes tocilizumab MESH:C502936
400 13263-13274 Chemical denotes tocilizumab MESH:C502936
401 12109-12117 Disease denotes COVID-19 MESH:C000657245
402 12258-12267 Disease denotes infection MESH:D007239
403 12351-12359 Disease denotes infected MESH:D007239
404 12447-12462 Disease denotes virus infection MESH:D001102
405 12618-12623 Disease denotes death MESH:D003643
406 12644-12653 Disease denotes mortality MESH:D003643
407 12779-12799 Disease denotes secondary infections MESH:D060085
408 13073-13077 Disease denotes ARDS MESH:D012128
409 13139-13154 Disease denotes viral infection MESH:D001102
410 13304-13312 Disease denotes COVID-19 MESH:C000657245
411 13379-13394 Disease denotes viral infection MESH:D001102
420 13586-13594 Species denotes patients Tax:9606
421 13831-13839 Species denotes patients Tax:9606
422 14029-14037 Species denotes patients Tax:9606
423 13579-13585 Disease denotes cancer MESH:D009369
424 13649-13657 Disease denotes COVID-19 MESH:C000657245
425 13824-13830 Disease denotes cancer MESH:D009369
426 13981-13989 Disease denotes COVID-19 MESH:C000657245
427 14022-14028 Disease denotes cancer MESH:D009369

2_test

Id Subject Object Predicate Lexical cue
32212881-31978293-46649251 506-507 31978293 denotes 2
32212881-32066541-46649252 1193-1194 32066541 denotes 5
32212881-32066541-46649253 1823-1824 32066541 denotes 5
32212881-28246584-46649254 3295-3296 28246584 denotes 8
32212881-30326787-46649255 3671-3672 30326787 denotes 9
32212881-32046555-46649256 3673-3675 32046555 denotes 10
32212881-32066541-46649257 4249-4250 32066541 denotes 5
32212881-32158597-46649258 4876-4878 32158597 denotes 12
32212881-31584861-46649259 5104-5106 31584861 denotes 13
32212881-30242316-46649260 5280-5282 30242316 denotes 14
32212881-32114747-46649261 6946-6948 32114747 denotes 16
32212881-29207939-46649262 9525-9527 29207939 denotes 21
32212881-29207939-46649263 9784-9786 29207939 denotes 21
32212881-30587227-46649264 9787-9789 30587227 denotes 22
32212881-32158597-46649265 10650-10652 32158597 denotes 12
32212881-31727344-46649266 10983-10985 31727344 denotes 23
32212881-32066541-46649267 11465-11466 32066541 denotes 5
32212881-25267464-46649268 12510-12512 25267464 denotes 24
32212881-23857287-46649269 12742-12744 23857287 denotes 25
32212881-23857287-46649270 12989-12991 23857287 denotes 25
T29510 506-507 31978293 denotes 2
T14915 1193-1194 32066541 denotes 5
T62223 1823-1824 32066541 denotes 5
T97016 3295-3296 28246584 denotes 8
T24715 3671-3672 30326787 denotes 9
T92909 3673-3675 32046555 denotes 10
T37185 4249-4250 32066541 denotes 5
T75660 4876-4878 32158597 denotes 12
T58724 5104-5106 31584861 denotes 13
T80029 5280-5282 30242316 denotes 14
T81092 6946-6948 32114747 denotes 16
T24725 9525-9527 29207939 denotes 21
T30266 9784-9786 29207939 denotes 21
T27463 9787-9789 30587227 denotes 22
T7954 10650-10652 32158597 denotes 12
T91256 10983-10985 31727344 denotes 23
T5245 11465-11466 32066541 denotes 5
T71372 12510-12512 25267464 denotes 24
T31365 12742-12744 23857287 denotes 25
T51545 12989-12991 23857287 denotes 25